Did Novo Nordisk executive faint in Oval Office? Company clarifies amid buzz about Gordon Findlay

Man Faints During Oval Office Press Conference

On Thursday, a press conference in the Oval Office was interrupted when a man fainted. President Donald Trump was announcing a deal with drugmakers to reduce the cost of obesity medications at the time.

Incident Details and Public Reaction

A widely shared video shows the man collapsing during the announcement. Independent journalist Eric Daugherty posted the video with the comments:

"A man just passed out during President Trump’s Oval Office announcement. Oz SPRUNG into action and assisted him."

"Pray for him."

Many viewers responded with prayers for the man’s recovery before the live feed was abruptly cut.

Clarifications on the Man's Identity

The man was initially identified as Gordon Findlay and was rumored to be a Novo Nordisk executive. An X account claimed:

"BREAKING: Novo Nordisk executive Gordon Findlay collapses during Trump's announcement in Oval Office, announcement suspended."

However, Novo Nordisk clarified the situation, stating that the man was not affiliated with their company. A spokesperson said:

"CEO Mike Doustdar and EVP, US Operations, Dave Moore were the only two Novo Nordisk representatives in the Oval Office. We hope the gentleman who suffered a medical incident today is okay."

White House Statement

White House Press Secretary Karoline Leavitt added further information, saying:

"During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted."

The announcement was temporarily halted due to the medical emergency.

Author's summary: A man fainted during President Trump’s Oval Office announcement on drug pricing, initially misidentified as a Novo Nordisk executive, but the company denied his association.

more

Hindustan Times Hindustan Times — 2025-11-06